Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Aspirin therapy, as compared with placebo, significantly reduced the rate of major vascular events with improved net clinical benefit and also reduced the rate of recurrent venous thromboembolism.

Using Low-Dose Aspirin to Prevent Recurrent Venous Thromboembolism